is tirzepatide safe for long term use Long-Term Use? A 2026 Clinical Perspective Long-Term Safety of Tirzepatide (Mounjaro):

Important safety note: If you have diabetes and take insulin or sulfonylurea medications, reducing your calorie or carbohydrate intake can increase the risk of hypoglycaemia (low blood glucose)

Reduced caloric intake combined with new metabolic signaling can affect energy availability, recovery capacity, and blood sugar stability during intense workouts

For example, early satiety or vomiting may suggest problems with gastric accommodation, while late satiation and/or vomiting may suggest abnormal gastric emptying

The term lipotropic means "fat-loving" and refers to compounds that help catalyze the breakdown of fat

A systematic review and network meta-analysis found that GLP-1RAs, while reducing total weight and fat mass, led to a decrease in lean body mass (mean difference 0.86 kg), with the loss accounting for approximately 25% of the total weight loss [14]

As of early 2025, well over 30 new GLP-1 drugs are in development